title: Salbutamol plus beclomethasone dipropionate, but not salbutamol alone, completely prevent early and late asthmatic responses to allergen.
abstract: The effect of a week treatment with inhaled salbutamol plus placebo (S+P) vs. salbutamol combined with beclomethasone dipropionate (S+BDP) on early and late asthmatic responses to inhaled allergen was studied in ten atopic patients in a randomized, double-blind, cross-over study. All patients had previously shown a dual type response to the specific bronchial provocative test (sBPT). Each patient performed two periods of treatment for a week, with a 15 day interval between them: (a) salbutamol 0.3 mg, tid + placebo; (b) salbutamol 0.3 mg+BDP 0.2 mg, tid; at the end of each treatment period, sBPT was performed and the last treatments were given 1.5-2 h before and 3-4 h after allergen challenge. S + BDP completely prevented both early and late responses to allergen, while S + P reduced but did not completely inhibit early and late responses. The difference between the two treatments was significant for early and late asthmatic responses. Non-specific bronchial hyperresponsiveness to methacholine was performed before each treatment period, after 6 days of treatment before sBPT and the day after sBPT at the end of the treatment period; there was only a mild increase in PD15FEV1 methacholine after 6 days of treatment with S + BDP in comparison with S + P treatment. These results suggest that salbutamol plus beclomethasone may be used effectively in the prophylaxis of early and late asthmatic reactions induced by allergen in sensitized subjects.
authors.affiliation: 2nd Medical Clinic, University of Pisa, Italy.
authors.forename: P L
authors.initials: PL
authors.lastname: Paggiaro
authors.forename: F L
authors.initials: FL
authors.lastname: Dente
authors.forename: B
authors.initials: B
authors.lastname: Vagaggini
authors.forename: E
authors.initials: E
authors.lastname: Bacci
authors.forename: D
authors.initials: D
authors.lastname: Talini
authors.forename: R
authors.initials: R
authors.lastname: Testi
authors.forename: C E
authors.initials: CE
authors.lastname: Mapp
authors.forename: L M
authors.initials: LM
authors.lastname: Fabbri
authors.forename: C
authors.initials: C
authors.lastname: Giuntini
mesh_terms: D000293:Adolescent; D000328:Adult; D000420:Albuterol / Q000627:therapeutic use*; D001249:Asthma / Q000503:physiopathology / Q000517:prevention & control*; D001507:Beclomethasone / Q000627:therapeutic use*; D001985:Bronchial Provocation Tests; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D013997:Time Factors
chemical_list: D001507:Beclomethasone; D000420:Albuterol